3rd Edition of International Cancer & Immuno-Oncology Conference
March 15-17, 2027 | Singapore
Cancer Drugs, Vaccines, and Drug Development
- Innovative Drug Discovery and Development
- Targeted Therapies and Small Molecule Inhibitors
- Cancer Vaccines and Immune Modulation
- Nanotechnology and Drug Delivery Systems
- Emerging Therapeutic Modalities
- Overcoming Drug Resistance and Toxicity
Cancer research has revolutionized how we combat this complex disease, with significant advancements in drugs, vaccines, and drug development processes. Targeted therapies, such as monoclonal antibodies and small-molecule inhibitors, are reshaping treatment by attacking specific cancer cells while minimizing damage to healthy tissues. Immunotherapy, including immune checkpoint inhibitors, has empowered the body’s immune system to combat tumors more effectively.
Cancer vaccines, both preventive and therapeutic, are gaining momentum. Preventive vaccines like HPV have shown success in reducing cervical cancer risks, while therapeutic vaccines aim to stimulate immune responses against existing tumors. Furthermore, innovative drug development strategies leverage precision medicine and AI-driven approaches to design tailored treatments, fostering hope for personalized cancer care.
With these advancements, cancer research continues to pave the way for transformative solutions that improve survival rates and quality of life for patients worldwide.
Rajvir Dahiya
University of California San Francisco, United States
Thomas Jay Webster
Brown University, United States
Yan Leyfman
NYP- Meyer Cancer Center, United StatesSubmit your abstract Today
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States